================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
July 8, 2005
------------------------------------------------
Date of Report (Date of earliest event reported)
PhotoMedex, Inc.
------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 0-11635 59-2058100
------------------------------ ------------ -------------------
(State or other (Commission (I.R.S. Employer
jurisdiction of incorporation) File Number) Identification No.)
147 Keystone Drive, Montgomeryville, Pennsylvania 18936
-------------------------------------------------------
(Address of principal executive offices)
(Zip Code)
(215) 619-3600
--------------------------------------------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 8.01 OTHER EVENT
On July 7, 2005, PhotoMedex, Inc. issued a press release which is
attached hereto as Exhibit 99.1 and is incorporated by reference
herein.
The press release announced that United Healthcare, a leading
healthcare provider serving more than 18 million individual
customers worldwide, had adopted a medical policy covering medically
necessary treatment of mild to moderate psoriasis using the
PhotoMedex XTRAC(R) laser system. The policy decision was effective
as of June 21, 2005 and includes Oxford Health Plans.
The information set forth under "Item 8.01, Other Event", including
the accompanying Exhibit 99.1, is being furnished in accordance with
interim guidance issued by the Securities and Exchange Commission in
Release No. 33-8216. The information contained herein and in the
accompanying exhibit shall not be incorporated by reference into any
filing of the Registrant, whether made before or after the date
hereof, regardless of any general incorporation language in such
filing, unless expressly incorporated by specific reference to such
filing. The information in this report, including the exhibit
hereto, shall not be deemed to be "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended or be otherwise
subject to the liabilities of that section or Sections 11 and 12 (a)
(2) of the Securities Act of 1933, as amended.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(C) EXHIBITS.
99.1 Press Release, dated July 7, 2005.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PHOTOMEDEX, INC.
Dated: July 8, 2005 By: /s/Jeffrey F. O'Donnell
-----------------------
Jeffrey F. O'Donnell
Chief Executive Officer
3
EXHIBIT INDEX
Exhibit Number Description
- -------------- --------------------------------------------------------------
99.1 Press release, dated July 7, 2005, regarding the announcement
of the favorable policy decision from United Healthcare for
the PhotoMedex XTRAC(R).
4